This paper summarizes the major dermatologic and immunologic complications associated with lithium carbonate ingestion. This drug has demonstrated proven efficacy in the treatment of bipolar affective disorder. This fact, the authors believe, outweighs its dermatologic complications, and only exacerbation of psoriasis warrants termination of therapy.
Get full access to this article
View all access options for this article.
References
1.
SchouM.Biology and Pharmacology of Lithium Ion, Pharm. Rev., 9, pp. 17–50, 1957.
2.
CadeJ. F.Lithium Salts in Treatment of Psychotic Excitement, Med. J. Austral., 36, pp. 349–354, 1949.
3.
GlesingerB.Evaluation of Lithium in Treatment of Psychotic Excitement, Med. J. Austral., 41, pp. 277–281, 1954.
4.
DonnellyE. F.GoodwinF. K.WaldmanI. N.Prediction of Antidepressant Response to Lithium, Amer. J. Psychiat., 135, pp. 552–556, 1978.
5.
RookA. and WickinsonD. S., The Principles of Diagnosis, Textbook of Dermatology, Oxford, Blackwell, p. 38, 1972.
6.
RifkinA.KurtinS. B.QuitkinF.Lithium-Induced Folliculitis, Amer. J. Psychiat., 130, pp. 1018–1019, 1973.
7.
CluffL. E. and CaldwellJ. R., Reactions to Drugs, ThornA. (ed.), Harrison's Principles of Internal Medicine, McGraw-Hill, New York, p. 350, 1977.
8.
HitchJ.Acneform Eruptions Induced by Drugs and Chemicals, J.A.M.A., 200, pp. 175–180, 1967.
9.
JeffersonJ. and GreistJ., A Primer of Lithium Therapy, Williams & Wilkins Co., Baltimore, p. 190, 1977.
10.
WeismanA. D., Adverse Effects of Lithium, A Primer of Lithium Therapy, Williams & Wilkins Co., Baltimore, pp. 192–195, 1977.
11.
PoseyR.Lithium Carbonate Dermatitis, J.A.M.A., 221, pp. 1517–1518, 1972.
12.
KurtinS. B.Lithium Carbonate Dermatitis, J.A.M.A., 223, pp. 802–803, 1973.
13.
BaerR. and HarrisH.Types of Cutaneous Reactions to Drugs, J.A.M.A., 202, pp. 105–109, 1967.
14.
CallawayC. L.HendrieH. C., and LubyE. D.Cutaneous Conditions Observed in Patients during Treatment with Lithium, Amer. J. Psychiat., 124, pp. 142–146, 1968.
15.
JeffersonJ. and GriestJ., Skin Manifestations of Lithium, A Primer of Lithium Therapy, Williams & Wilkins Co., Baltimore, p. 191, 1977.
16.
KusumiY.A Cutaneous Side Effect of Lithium: Report of Two Cases, Dis. of Nerv. Sys., 32, pp. 853–855, 1971.
17.
LoweN. and RidgewayH.Generalized Pustular Psoriasis Precipitated by Lithium Carbonate, Arch. Derm., 114, pp. 1788–1791, 1978.
18.
CarterT.The Relationship of Lithium Carbonate to Psoriasis, Psychosomatics, 13, pp. 325–327, 1972.
19.
SkovenI. and ThormannJ.Lithium and Psoriasis, Arch. Derm., 115, p. 1185, 1979.
20.
LazarusJ. and GilgorH.Lithium and Psoriasis, Arch. Derm., 115, p. 1183, 1979.
21.
VoorheesJ. J.MarceloC. L., and DuellE. A.Cyclic AMP, Cyclic GMP and Glucocorticoids as Potential Metabolic Regulators of Epidermal Proliferation, J. Invest. Derm., 65, pp. 179–190, 1975.
22.
SingerI. and RotenbergD.Mechanisms of Lithium Action, New Engl. J. Med., 289, pp. 254–257, 1973.
23.
CumberbatchJ. B.Skin Reactions to Beta Blockers, Brit. Med. J., 4, pp. 528–530, 1974.
24.
AdachiK.IizukaH.HalprinK., and LevineV.Epidermal Cyclic AMP is Not Decreased in Psoriasis Lesions, J. of Inv. Derm., 74, pp. 74–78, 1980.
25.
PriestlyA.Antinuclear Antibodies in Patients on Lithium, Brit. Med. J., 2, pp. 280–281, 1976.
26.
JohnstoneE. and WhaleyK.Antinuclear Antibodies in Psychiatric Illness: Their Relationship to Diagnosis and Drug Treatment, Brit. Med. J., 2, pp. 724–726, 1975.
